1002-57-9 | 8-Aminooctanoic acid

Packsize	Purity	Availability	Price	Discounted Price
1g	95%	in stock	$8.00	$5.00
5g	95%	in stock	$15.00	$10.00
10g	95%	in stock	$28.00	$19.00
25g	95%	in stock	$56.00	$39.00
100g	95%	in stock	$220.00	$154.00

Description

• Catalog Number: AA01394
• Chemical Name: 8-Aminooctanoic acid
• CAS Number: 1002-57-9
• Molecular Formula: C8H17NO2
• Molecular Weight: 159.2261
• MDL Number: MFCD00008245
• SMILES: NCCCCCCCC(=O)O
• NSC Number: 59019

Computed Properties

• Complexity: 104
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 7
• XLogP3: -2.6

Literature

• Stability assessment of a new antithrombotic small peptide, Arg-Gly-Asp-Trp-Arg (RGDWR), and its derivative.

  Biotechnology letters 20170801

• In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.

  Nuclear medicine and biology 20120701

• Bombesin analogues for gastrin-releasing peptide receptor imaging.

  Nuclear medicine and biology 20120501

• Determination of caprolactam and 6-aminocaproic acid in human urine using hydrophilic interaction liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120215

• Radiolabelled peptides for oncological diagnosis.

  European journal of nuclear medicine and molecular imaging 20120201

• Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep).

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20110701

• In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110301

• Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.

  Nuclear medicine and biology 20101001

• 3,5-Dicarboxyanilinium nitrate dihydrate.

  Acta crystallographica. Section E, Structure reports online 20100301

• NAD+ metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity.

  BMC chemical biology 20100101

• In vivo imaging of mesenchymal-epithelial transition factor (c-Met) expression using an optical imaging system.

  Bioconjugate chemistry 20090701

• Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts.

  Nuclear medicine and biology 20090501

• Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.

  Bioconjugate chemistry 20080901

• A new family of ATP-dependent oligomerization-macrocyclization biocatalysts.

  Nature chemical biology 20071001

• Covalent attachment of proteins to solid supports and surfaces via Sortase-mediated ligation.

  PloS one 20070101

• Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid.

  Journal of medicinal chemistry 20051020

• Application of capillary zone electrophoresis with indirect UV detection to the determination of a model drug, vigabatrin, in dosage forms.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20050803

• Peptide inhibitors of alpha-amylase based on tendamistat: development of analogues with omega-amino acids linking critical binding segments.

  Protein and peptide letters 20050401